These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1860679)

  • 21. Prevalence of core promotor and precore mutants of hepatitis B virus in thailand by RFLP and sequencing.
    Theamboonlers A; Tangkijvanich P; Jantaradsamee P; Hirsch P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Dec; 30(4):750-5. PubMed ID: 10928370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic mutations of precore region of hepatitis B virus in hepatitis B e antigen-negative patients with fulminant hepatitis B and translation of precore variants in vitro.
    Guo Y; Hou J; Luo K; Feng X
    Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):42-4. PubMed ID: 11242136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of hepatitis B virus genome recovered from Vietnamese patients with fulminant hepatitis in comparison with those of acute hepatitis.
    Yuasa R; Takahashi K; Dien BV; Binh NH; Morishita T; Sato K; Yamamoto N; Isomura S; Yoshioka K; Ishikawa T; Mishiro S; Kakumu S
    J Med Virol; 2000 May; 61(1):23-8. PubMed ID: 10745228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
    Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
    J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B.
    Friedt M; Gerner P; Lausch E; Trübel H; Zabel B; Wirth S
    Hepatology; 1999 Apr; 29(4):1252-8. PubMed ID: 10094972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete hepatitis B virus genome analysis in HBsAg positive mothers and their infants with fulminant hepatitis B.
    Friedt M; Gerner P; Wintermeyer P; Wirth S
    BMC Gastroenterol; 2004 Jun; 4():11. PubMed ID: 15186503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PreS and core gene heterogeneity in hepatitis B virus (HBV) genomes isolated from patients with long-lasting HBV chronic infection.
    Pollicino T; Campo S; Raimondo G
    Virology; 1995 Apr; 208(2):672-7. PubMed ID: 7747438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status.
    Honda A; Yokosuka O; Ehata T; Tagawa M; Imazeki F; Saisho H
    J Med Virol; 1999 Apr; 57(4):337-44. PubMed ID: 10089043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis.
    Hsu HY; Chang MH; Ni YH; Lin HH; Wang SM; Chen DS
    Hepatology; 1997 Sep; 26(3):786-91. PubMed ID: 9303514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
    Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP
    Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.
    Chen CH; Lee CM; Lu SN; Changchien CS; Wang JC; Wang JH; Hung CH; Hu TH
    J Hepatol; 2006 Jan; 44(1):76-82. PubMed ID: 16298013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels.
    Cabrerizo M; Bartolomé J; Iñigo ER; López-Alcorocho JM; Cotonat T; Carreño V
    J Med Virol; 1998 Dec; 56(4):294-9. PubMed ID: 9829632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML
    J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Detection of hepatitis B virus by using polymerase chain reaction and nonradioactive DNA probes. I. Identification of mutations in the precore region by PCR-direct sequencing and ASO probe method].
    Yamashita K; Mutoh T; Takarada Y; Otsuka N; Kagawa S; Matsuoka A
    Rinsho Byori; 1995 Aug; 43(8):836-42. PubMed ID: 7474444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.
    Revill PA; Littlejohn M; Ayres A; Yuen L; Colledge D; Bartholomeusz A; Sasaduesz J; Lewin SR; Dore GJ; Matthews GV; Thio CL; Locarnini SA
    AIDS; 2007 Aug; 21(13):1701-10. PubMed ID: 17690567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The precore mutation is associated with severity of liver damage in Brazilian patients with chronic hepatitis B.
    Rezende RE; Fonseca BA; Ramalho LN; Zucoloto S; Pinho JR; Bertolini DA; Martinelli AL
    J Clin Virol; 2005 Jan; 32(1):53-9. PubMed ID: 15572007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of basal core promoter and precore mutations in chronic hepatitis B.
    Ozgenc O; Ozacar T; Erensoy S; Inan N; Ari A; Kuruuzum Z; Bilgic A
    Hepatogastroenterology; 2007 Dec; 54(80):2319-23. PubMed ID: 18265656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Core promoter and precore mutants of hepatitis B virus: prevalence and clinical relevance in chronic hepatitis patients.
    Tangkijvanich P; Theamboonlers A; Jantaradsamee P; Hirsch P; Mahachai V; Suwangool P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):627-35. PubMed ID: 11414402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of precore-mutant hepatitis B virus genome in patients with acute and fulminant hepatitis using mutation site-specific assay (MSSA).
    Shiraki K; Hamada M; Sugimoto K; Ito T; Yamanaka T; Wagayama H; Shimizu A; Makino Y; Takase K; Nakano T; Tameda Y
    Hepatogastroenterology; 2002; 49(47):1352-6. PubMed ID: 12239941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.